Comparative efficacy of indacaterol in chronic obstructive pulmonary disease Full Text
International Journal of COPD,  Clinical Article

Ribeiro M et al. – Data from trials with the novel once–daily β2–agonist, indacaterol, indicate superior bronchodilation and clinical efficacy over twice–daily long–acting β2–agonists and at least equipotent bronchodilation as once–daily tiotropium. Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). It is likely that once–daily dosing of a bronchodilator would be a significant convenience and probably a compliance–enhancing advantage, leading to improved overall clinical outcomes in patients with COPD.

  • Long–acting bronchodilators have been shown to improve multiple clinical outcomes in chronic obstructive pulmonary disease (COPD) including lung function, symptoms, dyspnea, quality of life, and exacerbations.
  • Indacaterol is a novel, inhaled, long–acting β2–agonist providing 24–hour bronchodilation with once–daily dosing.
  • It is currently approved for the maintenance treatment of COPD to be administered as 150 or 300 µg once–daily doses as licensed in many countries and 75 µg as licensed in the US by means of a single–dose dry powder inhaler.
  • The data from clinical development support a favorable safety and tolerability profile within the β2–agonist drug class, with no relevant issues identified.
  • Current evidence indicates that indacaterol is suitable for use as first–line monotherapy in COPD patients with moderate disease (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage II) and beyond that do not require an inhaled corticosteroid (ICS) as per GOLD guidelines, or in combination with an ICS in severe or very severe patients with repeated exacerbations.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

2 Is non-invasive ventilation safe in acute severe asthma? Respirology, November 11, 2014    Review Article

3 Maternal vitamin D and E intakes during pregnancy are associated with asthma in children European Respiratory Journal , November 6, 2014    Clinical Article

4 Study shows possible link between asthma, cardiovascular disease University of Wisconsin-Madison News, November 20, 2014

5 Multicentric study on the beta-blocker use and relation with exacerbations in COPD Respiratory Medicine, June 19, 2014    Clinical Article

6 Efficacy of azithromycin in the treatment of bronchiectasis Respirology, September 9, 2014    Clinical Article

7 Efficacy of mycophenolate mofetil in sarcoidosis Respiratory Medicine, October 29, 2014    Review Article

8 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

9 Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD Full Text International Journal of COPD, November 24, 2014    Free full text    Clinical Article

10 Prophylactic antibiotic therapy after inhalation injury Burns, October 10, 2014    Clinical Article

11 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

12 Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease Respiratory Medicine, September 19, 2014    Clinical Article

13 Prevalence of chronic obstructive pulmonary disease among US working adults aged 40 to 70 years: National Health Interview Survey data 2004 to 2011 Journal of Occupational and Environmental Medicine, October 17, 2014    Clinical Article

14 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

15 A cytomorphometric analysis of pulmonary and mediastinal granulomas: Differentiating histoplasmosis from sarcoidosis by fine-needle aspiration Cancer Cytopathology, November 5, 2014    Review Article

16 Clinical phenotypes in sarcoidosis Current Opinion in Pulmonary Medicine, August 12, 2014    Review Article

17 Noninvasive ventilation with complex critical care ventilator in the treatment of acute exacerbation of chronic obstructive pulmonary disease The Journal of International Medical Research, August 12, 2014    Clinical Article

18 Endobronchial ultrasound-guided transbronchial biopsy and brushing: A comparative evaluation for the diagnosis of peripheral pulmonary lesions European Journal of Cardio-Thoracic Surgery, April 18, 2014    Review Article

19 Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen Respiratory Medicine, February 3, 2014    Clinical Article

20 Long-term outcomes after in-hospital CPR in older adults with chronic illness Chest, November 14, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore